Nanotechnology Now - Press Release: JMAR Retains Market Broker Relations to Aid Investor Communications Efforts

Home > Press > JMAR Retains Market Broker Relations to Aid Investor Communications Efforts

Abstract:
JMAR Technologies, Inc. (OTCBB:JMAR), a leading developer of advanced laser and high-resolution imaging and photonics technologies, announced today that it has retained the services of Market Broker Relations to expand the Company's strategic investor communications program.

JMAR Retains Market Broker Relations to Aid Investor Communications Efforts

San Diego, CA | Posted on May 29th, 2007

"JMAR is in a critical stage of its transition from government-funded R&D to a commercially-driven R&D center of excellence," said Neil Beer, President and CEO of JMAR. "Market Broker Relations will assist us in communicating the opportunities and potential payoffs of our nanotechnology products to existing and future shareholders."

Market Broker Relations, led by Howard Isaacs, has been associated with JMAR for over fifteen years. Their efforts will complement JMAR's Investor Relations firm, CEOcast, in widening investor and marketplace understanding of JMAR's nanotech product development plans and programs. "The investment community is unaware of the full potential of JMAR's arsenal of technology," continued Beer. "It's imperative that we improve our visibility."

####

About JMAR Technologies, Inc.
JMAR Technologies, Inc. is a leading innovator in the development of laser-based technology and x-ray processes for nano-scale imaging, analysis and fabrication. The Company is leveraging more than a decade of laser and photonics research to develop a portfolio of products with commercial applications in rapidly growing industries, while continuing to carry out research and development for the U.S. Government.

JMAR’s leading commercialized product, BioSentry™, is a contamination warning system for waterborne microorganisms. BioSentry™ uses laser-based, multi-angle light scattering technology to provide continuous, on-line, real-time monitoring for harmful microorganisms. BioSentry™ is targeted toward a number of applications across multiple markets, including homeland security, the cruise ship and beverage industries, pharmaceutical companies, and municipal water utilities.

JMAR’s pursuit of leading edge products targets nanotechnology, bioscience and the semiconductor industries with its BriteLight™ laser, a stand-alone product as well as the x-ray light source in nanolithography systems; the X-ray Microscope for 3D visualization of single cells and polymers; and the X-ray NanoProbe for enabling nano-scale interaction, analysis and materials modification. In addition, JMAR employs key strategic alliances for the production of a hazardous materials chemical sensor, and the prototyping and production of a nanoparticle ultra-thin coating system.

This news release contains certain “forward-looking statements.” Forward-looking statements are based on current expectations and assumptions and are inherently subject to risks and uncertainties, some of which cannot be predicted or quantified, and many of which are beyond the Company’s control. Actual results could differ materially from these forward-looking statements as a result of a number of factors, including the uncertainty of acceptance in the market for our products and technologies or the acceptance of our customers’ products or technologies which incorporate our products and technologies, the failure of our technology to perform as predicted, competition from alternative technologies, uncertainties as to the size of the markets, cost and margins for JMAR’s products, current or future government regulations affecting the use of JMAR’s products, the lack of availability of critical components, the degree of protection from future patents, other risks associated with the development or acquisition of new products or technologies and those risks detailed in the Company’s Form 10-K for the year ended December 31, 2006 filed with the SEC. Given these risks and uncertainties, investors are cautioned not to place undue reliance on such forward-looking statements and no assurances can be given that such statements will be achieved. JMAR Technologies, Inc. does not assume any duty to publicly update or revise the material contained herein.

For more information, please click here

Contacts:
JMAR Technologies, Inc.
Kathi Kirchmeier, Marketing Communications Manager
858-946-6800

If you have a comment, please Contact us.

Issuers of news releases, not 7th Wave, Inc. or Nanotechnology Now, are solely responsible for the accuracy of the content.

Bookmark: